Pulmicort Respules on Relapse Rates After Treatment in the ED

• Status: Withdrawn
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if the addition of budesonide to oral corticosteroids will result in a decrease in relapse rates compared to oral corticosteroids alone in children who are discharged from the ED after an asthma exacerbation. Secondly, that there will be an improvement in lung function, a decrease in beta-2 agonist use and an improvement in health-related quality of life compared to placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phoenix Children's Hospital
• Treatments: Budesonide

Criteria

Inclusion Criteria:

Patient is between the ages of 2 and 8

• Has previously been diagnosed with asthma by any physician

• Has presented to the ED with an asthma exacerbation judged by a physician that is believed would not required admission to the hospital

Exclusion Criteria:

• Children less than 2 years (wheezing may be due to bronchiolitis)

• Children who have been on oral or inhaled corticosteroid in the last week, are pregnant, or unavailable for follow-up

• Pregnant

• Has chronic lung diseases (i.e. cystic fibrosis)